On the 12 August 2022 it was notified endpoint for soft tissue repair were not met. Then on the 11 November an announcement was made they were. At the time analysis seemed to know or got the information as to why, before us and it only became clear what had happened at a next presentation q and a. At the time I had all the same questions and concerns many are asking now about GO. From my point of view, a similar event should have been expected and trust needs to be given to the company that such incidents are then handled in best interests of shareholders. As I believe they were at that time, this time too I'm confident . I am also confident short minded shareholders will forget rapidly after next July too.
I still dwell and judge the company on the 11 November fluff more than this GO announcement. Better to be critical before the next event then after
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)